Stereotactic body radiation therapy in the treatment of cancer patients with oligometastatic disease: a real world study.

Milica StefanovicGemma CalvetHéctor Pérez-MonteroAnna EsteveMontse Ventura BujalanceArturo Navarro-MartínMaria Dolores Arnaiz FernándezFerran Ferrer GonzálezSusanna Marin BorrasAlicia Lozano BorbalasMiriam Nuñez FernandezMiquel Macia GarauAnna Lucas CalduchFerran Guedea Edo

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2022)

SBRT appears to be well tolerated and safe approach in oligometastatic patients. Patients with good performance status and with primary breast, urological and colorectal cancer have higher OS compared with other malignancies. More studies are necessary to evaluate the prognostic factors in oligometastatic disease (OMD) in order to select patients who could benefit more from this therapeutic approach.

Keyphrases

prognostic factors
radiation therapy
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
rectal cancer
case control